Nationwide cohort study reveals alternative dosing maintains efficacy in metastatic renal cell carcinoma, suggesting flexible regimens can optimize cancer therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jakobsson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: